TREA

79272215 - SYNPLOGEN

Follow

Information

  • Trademark
  • 79272215
  • Serial Number
    79272215
  • Registration Number
    6115549
  • Filing Date
    August 22, 2019
    6 years ago
  • Registration Date
    August 04, 2020
    5 years ago
  • Transaction Date
    February 17, 2023
    2 years ago
  • Status Date
    August 04, 2020
    5 years ago
  • Published for Opposition Date
    May 19, 2020
    5 years ago
  • Location Date
    April 24, 2022
    3 years ago
  • Status Code
    700
  • Current Location
    TMO LAW OFFICE 123
    Employee Name
    VO, JULIE
  • Attorney Name
    Rebeccah Gan
    Law Office Assigned Location Code
    N50
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
SYNPLOGEN
Case File Statements
  • B00001: In the Statement, class 42 has been updated per the Restriction, and per the fnote dated April 20, 2022.
  • GS0421: Research and development relating to DNA synthesis technology; technical advisory services and * providing * information technology consulting services relating to DNA synthesis technology; research and development in the fields of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems; scientific research in the fields of genetics and genetic engineering; DNA screening for scientific research purposes; research and development, quality control for others, and technical advisory services relating thereto in the fields of protein, antibody, microorganisms, and cells; structural and functional analysis of the genome with genome synthesis technology; DNA screening for scientific research purposes with genome synthesis technology; research and development relating to genome synthesis technology; * providing * technical advisory services and information technology consulting services relating to genome synthesis technology; research and development, quality control for others, and technical advisory services relating thereto in the fields of protein, antibody, microorganisms, and cells, all with genome synthesis technology; research and development in the fields of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems, all with genome synthesis technology; scientific research in the fields of genetics and genetic engineering with genome synthesis technology; testing, inspection and research of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; development of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; * providing * technical advisory services relating to development of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; information technology services relating to development of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; testing, inspection and research relating to medical treatment or medical technology with genome synthesis technology; * providing * information technology consulting services for testing, inspection or research relating to medical treatment or medical technology with genome synthesis technology; testing and research relating to genome or gene to which genome synthesis technology is applied; research and development for the pharmaceutical industry and biotechnology industry with genome synthesis technology; research and development relating to biotechnology for others; research and development relating to genome synthesis technology for others; biotechnology research; research and development in the fields of genomics and biotechnology; technical advisory services in the fields of genomics and biotechnology; structural and functional analysis of genomes; testing, inspection or research on agriculture, livestock breeding or fisheries; development of pharmaceutical preparations and medicines; product development for others; research and development of new products for others; development of new technology for others in the fields of genomics and biotechnology; research and development of genome synthesis technology for others; research and development of new products for others with DNA synthesis technology; DNA synthesis services for others for scientific research purposes; research and development services in the field of gene expression systems; research and development services in the fields of microorganisms and cells; [ DNA sequence design services for scientific research purposes; ] research and development of microorganisms for others; research and development of microorganisms which produce useful substances for others; technical research in the field of microorganisms; bacteriological research; biological research
Case File Event Statements
  • 2/17/2023 - 2 years ago
    34 - INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE Type: INNA
  • 12/24/2022 - 3 years ago
    33 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INPR
  • 7/30/2022 - 3 years ago
    32 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 4/25/2022 - 3 years ago
    31 - LIMITATION FROM THE IB EXAMINED AND ENTERED Type: LIME
  • 4/24/2022 - 3 years ago
    30 - CORRECTION UNDER SECTION 7 ¿ PROCESSED Type: COC.
  • 2/5/2022 - 3 years ago
    29 - LIMITATION OF GOODS RECEIVED FROM IB Type: LIMG
  • 12/12/2020 - 5 years ago
    28 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 11/25/2020 - 5 years ago
    27 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 11/25/2020 - 5 years ago
    26 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 11/4/2020 - 5 years ago
    25 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 8/4/2020 - 5 years ago
    24 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 5/19/2020 - 5 years ago
    23 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/19/2020 - 5 years ago
    22 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/29/2020 - 5 years ago
    21 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/13/2020 - 5 years ago
    20 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/23/2020 - 5 years ago
    19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/23/2020 - 5 years ago
    18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/19/2020 - 5 years ago
    17 - ASSIGNED TO LIE Type: ALIE
  • 3/12/2020 - 5 years ago
    16 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/31/2020 - 5 years ago
    15 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 1/31/2020 - 5 years ago
    14 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/31/2020 - 5 years ago
    13 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/17/2020 - 5 years ago
    12 - REFUSAL PROCESSED BY IB Type: RFNT
  • 1/14/2020 - 5 years ago
    11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/14/2020 - 5 years ago
    10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/14/2020 - 5 years ago
    9 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/2/2020 - 5 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 1/2/2020 - 5 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 12/4/2019 - 6 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 12/3/2019 - 6 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/26/2019 - 6 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 11/22/2019 - 6 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/22/2019 - 6 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/21/2019 - 6 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR